572
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

LncRNA RUNX1-IT1 affects the differentiation of Th1 cells by regulating NrCAM transcription in Graves’ disease

, , , , &
Pages 921-933 | Received 05 Jul 2021, Accepted 23 Jan 2022, Published online: 27 Feb 2022

References

  • Yin Q, Shen L, Qi Y, et al. Decreased SIRT1 expression in the peripheral blood of patients with Graves’ disease. J Endocrinol. 2020;246(2):161–173.
  • Burch HB. Cooper DSJJotAMA: graves Disease. 314.
  • Maria Ramos-Levi A, and Marazuela M. Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinol Y Nutr. 2016;63(8):421–429.
  • Eshaghkhani Y, Sanati MH, Nakhjavani M, et al. Disturbed Th1 and Th2 balance in patients with Graves’ disease. Minerva Endocrinol. 2016;41(1):28–34.
  • Fu X-D. Non-coding RNA: a new frontier in regulatory biology. Natl Sci Rev. 2014;1(2):190–204.
  • Yi R, Yang L, Zeng S, et al. Different expression profile of mRNA and long noncoding RNA in autoimmune thyroid diseases patients. J Cell Biochem. 2019;120(12):19442–19456.
  • Wu G-C, Pan H-F, Leng R-X, et al. Emerging role of long noncoding RNAs in autoimmune diseases. Autoimmun Rev. 2015;14(9):798–805.
  • Wang P, Xue Y, Han Y, et al. The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation. Science. 2014;344(6181):310–313.
  • Zhang Y, Cao X. Long noncoding RNAs in innate immunity. Cell Mol Immunol. 2016;13(2):138–147.
  • Foronjy R. Commentary on: the potency of lncRNA MALAT1/miR-155 in altering asthmatic Th1/Th2 balance by modulation of CTLA4. Biosci Rep. 2020;40(5). 10.1042/BSR20190768
  • Christensen NJ, Habekost G, Bratholm P. Decrease in TSH Receptor Autoantibodies during Antithyroid Treatment: relationship with a Long Noncoding Heg RNA and Cdk1 mRNA in Mononuclear Cells. ISRN Endocrinol. 2011;2011:287052.
  • Huang Q, Cai W, Sun B, et al. Clinical study of rheumatoid arthritis patients associated with thyroid function abnormalities. Chin J Rheumatol. 2015;19(8):545–548.
  • Carbajal KS, Mironova Y, Ulrich-Lewis JT, et al. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. J Iimmunol. 2015;195(6):2552–2559.
  • Sytnyk V, Leshchyns’ka I, Schachner M. Neural Cell Adhesion Molecules of the Immunoglobulin Superfamily Regulate Synapse Formation, Maintenance, and Function. Trends Neurosci. 2017;40(5):295–308.
  • Zhang Y, Sui F, Ma J, et al. Positive Feedback Loops Between NrCAM and Major Signaling Pathways Contribute to Thyroid Tumorigenesis. J Clin Endocrinol Metab. 2017;102(2):613–624.
  • Hui Y, Huang Y, Ding X, et al. MicroRNA-152 suppresses cell proliferation and tumor growth of bladder cancer by targeting KLF5 and MKK7. Aging Pathobiology Ther. 2019;1(1):10–16.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods. 2001;25(4):402–408.
  • Fallahi P, Ferrari SM, Ragusa F, et al. Th1 Chemokines in Autoimmune Endocrine Disorders. J Clin Endocrinol Metab. 2020;105(4):1046–1060.
  • Hur K, Kim S-H, and Kim J-M. Potential Implications of Long Noncoding RNAs in Autoimmune Diseases. Immune Netw. 2019;19(1).
  • Yan PH, Wang L, Chen H, et al. LncRNA RUNX1-IT1 inhibits proliferation and promotes apoptosis of hepatocellular carcinoma by regulating MAPK pathways. Eur Rev Med Pharmacol Sci. 2019;23(19):8287–8294.
  • Sun L, Wang L, and Chen T, et al. LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells. Cell Death Dis. 2020;11:2.
  • Yang K, Hou Y, Li A, et al. Identification of a six-lncRNA signature associated with recurrence of ovarian cancer. Sci Rep. 2017;7(1):7.
  • Shi J, Zhong X, Song Y, et al. Long non-coding RNA RUNX1-IT1 plays a tumour-suppressive role in colorectal cancer by inhibiting cell proliferation and migration. Cell Biochem Funct. 2019;37(1):11–20.
  • Liu S, Zhang J, and Yin L, et al. The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion. Cell Death Dis. 2020;11(6):412.
  • Fasihi A, Heydari-Zarnagh H, Zahedi M, et al. Study and Characterization of Long Non-coding RUNX1-IT1 among Large Artery Atherosclerosis Stroke Patients Based on the ceRNA Hypothesis. J Mol Neurosci. 2020;71(3):455–465.
  • Pellegrino M, Traversi G, Arena A, et al. Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients. Plos One. 2020;15(1):e0228296.
  • Takatori H, Kawashima H, Suzuki K, et al. Role of p53 in Systemic Autoimmune Diseases. Crit Rev Immunol. 2014;34(6):509–516.
  • Leite JL, Bufalo NE, Santos RB, et al. Herpesvirus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves’ disease. Eur J Endocrinol. 2010;162(2):315–321.
  • Chen RH, Chang CT, Wang TY, et al. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases. J Clin Lab Anal. 2008;22(5):321–326.
  • Inoue N, Watanabe M, Nakaguchi A, et al. Functional polymorphisms affecting Th1 differentiation are associated with the severity of autoimmune thyroid diseases. Endocr J. 2017;64(7):695–703.
  • Gonzalez-Amaro R, Marazuela M. T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity. Endocrine. 2016;52(1):30–38.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.